Home › Funds › Frazier Life Sciences Management, L.P. › ERAS
Frazier Life Sciences Management, L.P. position in ERAS
ERASCA INC · Health Care
Frazier Life Sciences Management, L.P. reported holding 24,975,188 shares of ERAS (ERASCA INC) in its Q2 2026 13F filing — a position valued at US$457.5M, representing 9.96% of its reported portfolio and ranking #3 among its reported holdings. Frazier Life Sciences Management, L.P. has disclosed ERAS holdings in 9 of the last 9 reported quarters, going back to Q2 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Frazier Life Sciences Management, L.P.'s ERAS position evolved
Frazier Life Sciences Management, L.P. first disclosed a stake in ERAS in Q2 2024 at 16,216,216 shares (US$38.3M). The position peaked in Q2 2026 at 24,975,188 shares, worth US$457.5M. Across 9 filings, Frazier Life Sciences Management, L.P. increased the stake 5 time(s), trimmed it 0 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 24,975,188 shares valued at US$457.5M — an increase of 300,000 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 16.22M | $38.27M | New |
| Q3 2024 | 19.39M | $52.94M | Add |
| Q4 2024 | 19.39M | $48.67M | Hold |
| Q1 2025 | 22.58M | $30.93M | Add |
| Q2 2025 | 22.73M | $28.87M | Add |
| Q3 2025 | 22.73M | $49.55M | Hold |
| Q4 2025 | 22.73M | $84.55M | Hold |
| Q1 2026 | 24.68M | $399.24M | Add |
| Q2 2026 | 24.98M | $457.55M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ERAS and 13F data
ERAS (ERASCA INC) is a Health Care company. 78 other funds we track also report a position in ERAS — the largest reported positions include RTW INVESTMENTS, LP (US$328.8M), Venrock Adviser, LLC (US$327.8M), Logos Global Management LP (US$222.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ERAS
- RTW INVESTMENTS, LP 17.95M sh · $328.78M · Q2 2026
- Venrock Adviser, LLC 17.89M sh · $327.78M · Q2 2026
- Logos Global Management LP 12.15M sh · $222.59M · Q2 2026
- Siren, L.L.C. 11.40M sh · $208.81M · Q2 2026
- Paradigm Biocapital Advisors LP 9.55M sh · $174.96M · Q2 2026
- ARCH Venture Management, LLC 7.09M sh · $129.92M · Q2 2026
- Cormorant Asset Management, LP 6.00M sh · $109.92M · Q2 2026
- Affinity Asset Advisors, LLC 5.25M sh · $96.18M · Q2 2026
- Vivo Capital, LLC 4.13M sh · $75.61M · Q2 2026
- a16z Capital Management, L.L.C. 2.86M sh · $52.44M · Q2 2026
- Soleus Capital Management, L.P. 2.70M sh · $49.46M · Q2 2026
- SAMLYN CAPITAL, LLC 2.26M sh · $41.35M · Q2 2026
More on Frazier Life Sciences Management, L.P.
FAQ
How long has Frazier Life Sciences Management, L.P. held ERAS?
Frazier Life Sciences Management, L.P. has disclosed ERAS holdings in 9 of the last 9 reported quarters, going back to Q2 2024.
What is Frazier Life Sciences Management, L.P.'s current position in ERAS?
As of Q2 2026, Frazier Life Sciences Management, L.P. holds 24.98M shares of ERAS (ERASCA INC), valued at $457.55M, representing 9.96% of its reported portfolio and ranking #3.
Has Frazier Life Sciences Management, L.P. been buying or selling ERAS?
In the latest 13F filing (Q2 2026), Frazier Life Sciences Management, L.P. increased its position in ERAS. The position peaked in Q2 2026 at 24.98M shares.
Which other funds hold ERAS?
Other major institutional holders of ERAS include RTW INVESTMENTS, LP, Venrock Adviser, LLC, Logos Global Management LP, among 78 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.